Psychedelics research gains support from the Trump administration for treating PTSD and mental health conditions, with ...

An annual review of clinical trials for Alzheimer's disease highlights a growing number of active trials—and drugs—in the ...

These individuals often “travel” between therapeutic areas and phases—crossing ... of duplicate and professional research subjects. Protect your trial, your data, and your participants—start with ...

At a panel at CTO West Coast, experts from biopharmaceutical companies outlined innovative strategies to shape the future of ...

Research findings suggest that a new blood test for Alzheimer’s disease has shown promise in accurately identifying people ...

Primary progressive aphasia is a neurological condition that causes a gradual decline in language abilities. There is no cure ...

Luton, Bedfordshire, United Kingdom, June 05, 2025 (GLOBE NEWSWIRE) -- The global pediatric glioma drugs market is poised for substantial growth, with an estimated value of approximately USD 5 billion ...

Highlights from the 2025 Global Equine Endocrinology Symposium included never-before-presented study results on insulin ...

Divya met her best friend when she was just 4 years old. They’ve been through all the phases of childhood and adolescence ...

BioNet and Bio Farma partner to develop TdaP vaccines for ASEAN region, targeting 10-15 million doses annually worth $200 ...

GLP-1 drugs alter taste perception… and commonly disrupt the perception of sweetness, bitterness, fatty foods and even ...

A startup founded by two MUSC Hollings Cancer Center researchers is the only South Carolina company selected to participate ...